Last Updated on June 22, 2023

European Heart Journal - Cardiovascular Pharmacotherapy- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: Oxford University Press

Abbreviation: Eur. Heart J. - Cardiovasc. Pharmacother.




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

3.62

SJR

 1.641

h-Index

 35

Rank

 1824

Important Details

Title European Heart Journal - Cardiovascular Pharmacotherapy
Standard Abbreviation Eur. Heart J. - Cardiovasc. Pharmacother.
Type of Publication Journal
Discipline Cardiology and Cardiovascular Medicine (Q1); Pharmacology (medical) (Q1)
Impact Score 3.62
SCImago Journal Rank (SJR) 1.641
h-index 35
Overall Rank 1824
Publisher Name Oxford University Press
Publication Country United Kingdom
International Standard Serial Number (ISSN) 20556837, 20556845
Coverage and History 2015-2022
Best Quartile Q1
Total Citations Received
(Last 3 Year)
962

About European Heart Journal - Cardiovascular Pharmacotherapy


European Heart Journal - Cardiovascular Pharmacotherapy is a journal published by Oxford University Press. This journal covers the area[s] related to Cardiology and Cardiovascular Medicine, Pharmacology (medical), etc. The coverage history of this journal is as follows: 2015-2022. The rank of this journal is 1824. This journal's impact score, h-index, and SJR are 3.62, 35, and 1.641, respectively. The ISSN of this journal is/are as follows: 20556837, 20556845.

The best quartile of European Heart Journal - Cardiovascular Pharmacotherapy is Q1. This journal has received a total of 962 citations during the last three years (Preceding 2022).


European Heart Journal - Cardiovascular Pharmacotherapy Impact Score 2022-2023


The latest impact score (IS) of the European Heart Journal - Cardiovascular Pharmacotherapy is 3.62. It is computed in the year 2023 as per its definition and based on Scopus data. 3.62

It is decreased by a factor of around 1.33, and the percentage change is -26.87% compared to the preceding year 2021, indicating a falling trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of European Heart Journal - Cardiovascular Pharmacotherapy Impact Score 2023


Impact Score 2022 of European Heart Journal - Cardiovascular Pharmacotherapy is 3.62. If a similar downward trend continues, IS may decrease in 2023 as well.


Impact Score Graph


Check below the Impact Score trends of European Heart Journal - Cardiovascular Pharmacotherapy. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 3.62
2021 4.95
2020 2.93
2019 3.25
2018 3.61
2017 3.15
2016 1.92
2015 0.00

European Heart Journal - Cardiovascular Pharmacotherapy h-index


  Table Setting

The h-index of European Heart Journal - Cardiovascular Pharmacotherapy is 35. By definition of the h-index, this journal has at least 35 published articles with more than 35 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




European Heart Journal - Cardiovascular Pharmacotherapy ISSN


The International Standard Serial Number (ISSN) of European Heart Journal - Cardiovascular Pharmacotherapy is/are as follows: 20556837, 20556845.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

European Heart Journal - Cardiovascular Pharmacotherapy Ranking and SCImago Journal Rank (SJR)


The European Heart Journal - Cardiovascular Pharmacotherapy is ranked 1824 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 1.641.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


European Heart Journal - Cardiovascular Pharmacotherapy Publisher


Table Setting

The publisher of European Heart Journal - Cardiovascular Pharmacotherapy is Oxford University Press. The publishing house of this journal is located in the United Kingdom. Its coverage history is as follows: 2015-2022.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of European Heart Journal - Cardiovascular Pharmacotherapy is Eur. Heart J. - Cardiovasc. Pharmacother.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Eur. Heart J. - Cardiovasc. Pharmacother.') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in European Heart Journal - Cardiovascular Pharmacotherapy


If your area of research or discipline is related to Cardiology and Cardiovascular Medicine, Pharmacology (medical), etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of European Heart Journal - Cardiovascular Pharmacotherapy?

The latest impact score of European Heart Journal - Cardiovascular Pharmacotherapy is 3.62. It is computed in the year 2023.


What is the h-index of European Heart Journal - Cardiovascular Pharmacotherapy?

The latest h-index of European Heart Journal - Cardiovascular Pharmacotherapy is 35. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of European Heart Journal - Cardiovascular Pharmacotherapy?

The latest SCImago Journal Rank (SJR) of European Heart Journal - Cardiovascular Pharmacotherapy is 1.641. It is calculated in the year 2023.


What is the ranking of European Heart Journal - Cardiovascular Pharmacotherapy?

The latest ranking of European Heart Journal - Cardiovascular Pharmacotherapy is 1824. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of European Heart Journal - Cardiovascular Pharmacotherapy?

European Heart Journal - Cardiovascular Pharmacotherapy is published by Oxford University Press. The publication country of this journal is United Kingdom.


What is the abbreviation of European Heart Journal - Cardiovascular Pharmacotherapy?

This standard abbreviation of European Heart Journal - Cardiovascular Pharmacotherapy is Eur. Heart J. - Cardiovasc. Pharmacother..


Is "European Heart Journal - Cardiovascular Pharmacotherapy" a Journal, Conference or Book Series?

European Heart Journal - Cardiovascular Pharmacotherapy is a journal published by Oxford University Press.


What is the scope of European Heart Journal - Cardiovascular Pharmacotherapy?

The scope of European Heart Journal - Cardiovascular Pharmacotherapy is as follows:

  • Cardiology and Cardiovascular Medicine
  • Pharmacology (medical)

For detailed scope of European Heart Journal - Cardiovascular Pharmacotherapy, check the official website of this journal.


What is the ISSN of European Heart Journal - Cardiovascular Pharmacotherapy?

The International Standard Serial Number (ISSN) of European Heart Journal - Cardiovascular Pharmacotherapy is/are as follows: 20556837, 20556845.


What is the best quartile for European Heart Journal - Cardiovascular Pharmacotherapy?

The best quartile for European Heart Journal - Cardiovascular Pharmacotherapy is Q1.


What is the coverage history of European Heart Journal - Cardiovascular Pharmacotherapy?

The coverage history of European Heart Journal - Cardiovascular Pharmacotherapy is as follows 2015-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Analysis in Theory and Applications Journal Springer Netherlands 19346 11 0.00
Istanbul University - Journal of Electrical and Electronics Engineering Journal University of Istanbul 24654 0 0.00
Business Strategy Review Journal Wiley-Blackwell Publishing Ltd 31512 33 0.04
Mathematical Modelling and Analysis Journal Vilnius Gediminas Technical University 11315 27 1.75
International Journal of Applied Linguistics Journal Wiley-Blackwell Publishing Ltd 7321 51 2.00
Indian Phytopathology Journal Springer Nature 14222 11 1.33
Archives of the Balkan Medical Union Journal Balkan medical union 23243 10 0.24
Acta Periodica Technologica Journal University of Novi Sad, Faculty of Technology 19470 18 0.62
Metascience Journal Springer Nature 13645 3 0.13
Journal of Medical Toxicology Journal Springer New York 8639 55 2.01

Check complete list




European Heart Journal - Cardiovascular Pharmacotherapy Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 3.62
2021 4.95
2020 2.93
2019 3.25
2018 3.61
2017 3.15
2016 1.92
2015 0.00



Top Journals/Conferences in Cardiology and Cardiovascular Medicine

Journal of the American College of Cardiology
Elsevier USA | United States

Circulation
Lippincott Williams and Wilkins Ltd. | United States

JAMA Cardiology
American Medical Association | United States

Nature Reviews Cardiology
Nature Publishing Group | United Kingdom

European Journal of Heart Failure
Wiley-Blackwell | United States

JACC: Heart Failure
Elsevier BV | Netherlands

Circulation Research
Lippincott Williams and Wilkins Ltd. | United States

JACC: Cardiovascular Imaging
Elsevier Inc. | United States

European Heart Journal
Oxford University Press | United Kingdom

Circulation: Heart Failure
Lippincott Williams and Wilkins Ltd. | United States

Circulation: Arrhythmia and Electrophysiology
Lippincott Williams and Wilkins Ltd. | United States

Circulation. Genomic and precision medicine
Lippincott Williams and Wilkins Ltd. | United States

JACC: Cardiovascular Interventions
Elsevier Inc. | United States

Arteriosclerosis, Thrombosis, and Vascular Biology
Lippincott Williams and Wilkins Ltd. | United States

Stroke
American Heart Association | United States

See All

Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United States

npj Vaccines
Nature Publishing Group | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

American Journal of Transplantation
Wiley-Blackwell Publishing Ltd | United Kingdom

Journal of Biomedical Science
BioMed Central Ltd. | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

Drugs
Adis International Ltd | United Kingdom

Rheumatology
Oxford University Press | United Kingdom

Acta Pharmacologica Sinica
Nature Publishing Group | United Kingdom

Vaccines
Multidisciplinary Digital Publishing Institute (MDPI) | Switzerland

BioDrugs
Adis International Ltd | United Kingdom

Clinical Pharmacology and Therapeutics
Wiley-Blackwell | United States

Drug and Alcohol Dependence
Elsevier Ireland Ltd | Ireland

Journal of Addiction Medicine
Lippincott Williams and Wilkins Ltd. | United States

See All